The erectile disorder in males is more specifically treated with which of the following agents?
**Core Concept**
The management of erectile dysfunction involves targeting the nitric oxide-cyclic guanosine monophosphate (cGMP) pathway, which plays a crucial role in penile erection. Phosphodiesterase type 5 (PDE5) inhibitors are a class of medications that selectively inhibit the enzyme PDE5, thereby increasing the levels of cGMP in the penis and facilitating erection.
**Why the Correct Answer is Right**
PDE5 inhibitors, such as sildenafil (Viagra), tadalafil (Cialis), vardenafil (Levitra), and avanafil (Stendra), work by inhibiting the breakdown of cGMP in the smooth muscle cells of the corpus cavernosum. This leads to increased blood flow into the penis and relaxation of the smooth muscle, resulting in an erection. The efficacy of PDE5 inhibitors is enhanced by the presence of nitric oxide, which stimulates the release of cGMP.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect as it does not specify a treatment for erectile dysfunction.
**Option B:** This option is incorrect as it is a class of medications used for treating erectile dysfunction, but it is not a specific agent.
**Option C:** This option is incorrect as it is a medication used for treating conditions such as hypertension, angina, and heart failure, but it is not a specific agent for erectile dysfunction.
**Clinical Pearl / High-Yield Fact**
PDE5 inhibitors can cause a temporary decrease in blood pressure, and patients with a history of cardiovascular disease should be monitored closely when initiating therapy.
**Correct Answer:** C. Sildenafil (Viagra).